Optimal Use of Bendamustine in Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphomas, and Multiple Myeloma: Treatment Recommendations From an International Consensus Panel
Authors:
- Bruce D. ChesonBCBruce D. Cheson
- Clemens-Martin WendtnerCWClemens-Martin Wendtner
- Angelika PieperAPAngelika Pieper
- Martin DreylingMDMartin Dreyling
- Jonathan FriedbergJFJonathan Friedberg
- Dieter HoelzerDHDieter Hoelzer
- Philippe MoreauPMPhilippe Moreau
- John GribbenJGJohn Gribben
- Stefan KnopSKStefan Knop
- Marco MontilloMMMarco Montillo
- Mathias RummelMRMathias Rummel
- 1 February 2010
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 10 (1) , 21-27
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2009
- Bendamustine: Rebirth of an Old DrugJournal of Clinical Oncology, 2009
- Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent StudyJournal of Clinical Oncology, 2008
- Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating AgentsClinical Cancer Research, 2008
- A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumorsAnti-Cancer Drugs, 2007
- A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumoursBritish Journal of Cancer, 2007
- High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomasJournal of Cancer Research and Clinical Oncology, 2002
- Weekly administration of bendamustine: A phase I study in patients with advanced progressive solid tumoursAnnals of Oncology, 2000
- Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumoursJournal of Cancer Research and Clinical Oncology, 2000
- Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase II studyJournal of Cancer Research and Clinical Oncology, 1998